US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist
  • 8.920
  • +0.920+11.50%
Trading Jun 3 12:20 ET
569.11MMarket Cap-9291P/E (TTM)

Larimar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
119.12%16.73M
14.32%41.76M
35.66%14.16M
21.45%10.34M
10.74%9.62M
-14.07%7.64M
-27.62%36.53M
14.89%10.44M
-49.12%8.51M
-30.74%8.69M
Selling and administrative expenses
23.41%3.8M
14.76%14.09M
9.10%3.51M
28.08%3.75M
23.07%3.75M
-0.19%3.08M
1.72%12.28M
15.28%3.22M
8.48%2.93M
-11.57%3.04M
-General and administrative expense
23.41%3.8M
14.76%14.09M
9.10%3.51M
28.08%3.75M
23.07%3.75M
-0.19%3.08M
1.72%12.28M
15.28%3.22M
8.48%2.93M
-11.57%3.04M
Research and development costs
183.63%12.94M
14.10%27.67M
47.52%10.65M
17.97%6.59M
4.09%5.88M
-21.43%4.56M
-36.84%24.25M
14.72%7.22M
-60.21%5.58M
-37.99%5.64M
Operating profit
-119.12%-16.73M
-14.32%-41.76M
-35.66%-14.16M
-21.45%-10.34M
-10.74%-9.62M
14.07%-7.64M
27.62%-36.53M
-14.89%-10.44M
49.12%-8.51M
30.74%-8.69M
Net non-operating interest income expense
Other net income (expense)
87.22%2.08M
310.67%4.81M
15.29%1.17M
560.62%1.28M
6,170.00%1.25M
2,083.93%1.11M
784.80%1.17M
2,212.50%1.01M
357.33%193K
130.30%20K
Other non- operating income (expenses)
87.22%2.08M
310.67%4.81M
15.29%1.17M
560.62%1.28M
6,170.00%1.25M
2,083.93%1.11M
784.80%1.17M
2,212.50%1.01M
357.33%193K
130.30%20K
Income before tax
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
50.49%-8.32M
31.26%-8.67M
Income tax
Net income
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
50.49%-8.32M
31.26%-8.67M
Net income continuous Operations
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
50.49%-8.32M
31.26%-8.67M
Minority interest income
Net income attributable to the parent company
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
50.49%-8.32M
31.26%-8.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
50.49%-8.32M
31.26%-8.67M
Basic earnings per share
-80.00%-0.27
38.69%-0.84
-38.10%-0.29
43.24%-0.21
59.57%-0.19
69.39%-0.15
53.56%-1.37
58.00%-0.21
59.78%-0.37
40.51%-0.47
Diluted earnings per share
-80.00%-0.27
38.69%-0.84
-38.10%-0.29
43.24%-0.21
59.57%-0.19
69.39%-0.15
53.56%-1.37
58.00%-0.21
59.78%-0.37
40.51%-0.47
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 119.12%16.73M14.32%41.76M35.66%14.16M21.45%10.34M10.74%9.62M-14.07%7.64M-27.62%36.53M14.89%10.44M-49.12%8.51M-30.74%8.69M
Selling and administrative expenses 23.41%3.8M14.76%14.09M9.10%3.51M28.08%3.75M23.07%3.75M-0.19%3.08M1.72%12.28M15.28%3.22M8.48%2.93M-11.57%3.04M
-General and administrative expense 23.41%3.8M14.76%14.09M9.10%3.51M28.08%3.75M23.07%3.75M-0.19%3.08M1.72%12.28M15.28%3.22M8.48%2.93M-11.57%3.04M
Research and development costs 183.63%12.94M14.10%27.67M47.52%10.65M17.97%6.59M4.09%5.88M-21.43%4.56M-36.84%24.25M14.72%7.22M-60.21%5.58M-37.99%5.64M
Operating profit -119.12%-16.73M-14.32%-41.76M-35.66%-14.16M-21.45%-10.34M-10.74%-9.62M14.07%-7.64M27.62%-36.53M-14.89%-10.44M49.12%-8.51M30.74%-8.69M
Net non-operating interest income expense
Other net income (expense) 87.22%2.08M310.67%4.81M15.29%1.17M560.62%1.28M6,170.00%1.25M2,083.93%1.11M784.80%1.17M2,212.50%1.01M357.33%193K130.30%20K
Other non- operating income (expenses) 87.22%2.08M310.67%4.81M15.29%1.17M560.62%1.28M6,170.00%1.25M2,083.93%1.11M784.80%1.17M2,212.50%1.01M357.33%193K130.30%20K
Income before tax -124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M50.49%-8.32M31.26%-8.67M
Income tax
Net income -124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M50.49%-8.32M31.26%-8.67M
Net income continuous Operations -124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M50.49%-8.32M31.26%-8.67M
Minority interest income
Net income attributable to the parent company -124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M50.49%-8.32M31.26%-8.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M50.49%-8.32M31.26%-8.67M
Basic earnings per share -80.00%-0.2738.69%-0.84-38.10%-0.2943.24%-0.2159.57%-0.1969.39%-0.1553.56%-1.3758.00%-0.2159.78%-0.3740.51%-0.47
Diluted earnings per share -80.00%-0.2738.69%-0.84-38.10%-0.2943.24%-0.2159.57%-0.1969.39%-0.1553.56%-1.3758.00%-0.2159.78%-0.3740.51%-0.47
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.21%